This was supported by the finding that the pretreatment of malignant cells with quercetin, a biochemical inhibitor of Hsps (especially Hsp27 and Hsp40), reduced cancer cell survival, potentiating 5-FU and carboplatin-mediated hepatoma cell death. The gene discussed is DNAJB1; the disease is hepatocellular carcinoma.